Percheron Therapeutics (AU:PER) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Percheron Therapeutics’ director Charmaine Gittleson has increased her indirect stake in the company by purchasing an additional 1,666,666 fully paid ordinary shares, bringing her total to 2,399,999 shares. This move signals potential confidence in the company’s future prospects, likely interesting investors and market watchers.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.
